482 related articles for article (PubMed ID: 26525215)
1. Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy.
Wisely CE; Hadziahmetovic M; Reem RE; Hade EM; Nag S; Davidorf FH; Martin D; Cebulla CM
Brachytherapy; 2016; 15(1):12-22. PubMed ID: 26525215
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of choroidal melanomas treated with eye physics plaques: A 25-year review.
Le BHA; Kim JW; Deng H; Rayess N; Jennelle RL; Zhou SY; Astrahan MA; Berry JL
Brachytherapy; 2018; 17(6):981-989. PubMed ID: 30082188
[TBL] [Abstract][Full Text] [Related]
3. Vision Loss Following Episcleral Brachytherapy for Uveal Melanoma: Development of a Vision Prognostication Tool.
Aziz HA; Singh N; Bena J; Wilkinson A; Singh AD
JAMA Ophthalmol; 2016 Jun; 134(6):615-20. PubMed ID: 27101414
[TBL] [Abstract][Full Text] [Related]
4. Repeat Episcleral Plaque Brachytherapy: Clinical Outcomes in Patients Treated for Locally Recurrent Posterior Uveal Melanoma.
King B; Morales-Tirado VM; Wynn HG; Gao BT; Ballo MT; Wilson MW
Am J Ophthalmol; 2017 Apr; 176():40-45. PubMed ID: 28048976
[TBL] [Abstract][Full Text] [Related]
5. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
[TBL] [Abstract][Full Text] [Related]
6. Early outcomes of uveal melanoma treated with intraoperative ultrasound guided brachytherapy using custom built plaques.
Tann AW; Teh BS; Scarboro SB; Lewis GD; Bretana ME; Croft PC; Raizen Y; Butler EB; Kim RS; Chevez-Barrios P; Schefler AC
Pract Radiat Oncol; 2017; 7(4):e275-e282. PubMed ID: 28377140
[TBL] [Abstract][Full Text] [Related]
7. NEW ULTRA-WIDE-FIELD ANGIOGRAPHIC GRADING SCHEME FOR RADIATION RETINOPATHY AFTER IODINE-125 BRACHYTHERAPY FOR UVEAL MELANOMA.
McCannel TA; Kim E; Kamrava M; Lamb J; Caprioli J; Yang D; McCannel CA
Retina; 2018 Dec; 38(12):2415-2421. PubMed ID: 29016456
[TBL] [Abstract][Full Text] [Related]
8. Visual acuity, oncologic, and toxicity outcomes with
Patel KR; Prabhu RS; Switchenko JM; Chowdhary M; Craven C; Mendoza P; Danish H; Grossniklaus HE; Aaberg TM; Aaberg T; Reddy S; Butker E; Bergstrom C; Crocker IR
Brachytherapy; 2017; 16(3):646-653. PubMed ID: 28262517
[TBL] [Abstract][Full Text] [Related]
9. Pigmented episcleral deposits after brachytherapy of uveal melanoma.
Toivonen P; Kivelä T
Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837
[TBL] [Abstract][Full Text] [Related]
10. Plaque brachytherapy for uveal melanoma: a vision prognostication model.
Khan N; Khan MK; Bena J; Macklis R; Singh AD
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e285-90. PubMed ID: 22658514
[TBL] [Abstract][Full Text] [Related]
11. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques.
Puusaari I; Heikkonen J; Kivelä T
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045
[TBL] [Abstract][Full Text] [Related]
12. Iodine 125 brachytherapy with vitrectomy and silicone oil in the treatment of uveal melanoma: 1-to-1 matched case-control series.
McCannel TA; McCannel CA
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):347-52. PubMed ID: 24721588
[TBL] [Abstract][Full Text] [Related]
13. Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients.
Shields CL; Shields JA; Cater J; Gündüz K; Miyamoto C; Micaily B; Brady LW
Arch Ophthalmol; 2000 Sep; 118(9):1219-28. PubMed ID: 10980767
[TBL] [Abstract][Full Text] [Related]
14. 18 years' experience with high dose rate strontium-90 brachytherapy of small to medium sized posterior uveal melanoma.
van Ginderdeuren R; van Limbergen E; Spileers W
Br J Ophthalmol; 2005 Oct; 89(10):1306-10. PubMed ID: 16170122
[TBL] [Abstract][Full Text] [Related]
15. Uveal melanoma treated with iodine-125 episcleral plaque: an analysis of dose on disease control and visual outcomes.
Perez BA; Mettu P; Vajzovic L; Rivera D; Alkaissi A; Steffey BA; Cai J; Stinnett S; Dutton JJ; Buckley EG; Halperin E; Marks LB; Mruthyunjaya P; Kirsch DG
Int J Radiat Oncol Biol Phys; 2014 May; 89(1):127-36. PubMed ID: 24613808
[TBL] [Abstract][Full Text] [Related]
16. Factors predictive of radiation retinopathy post (125)Iodine brachytherapy for uveal melanoma.
Krema H; Xu W; Payne D; Vasquez LM; Pavlin CJ; Simpson R
Can J Ophthalmol; 2011 Apr; 46(2):158-63. PubMed ID: 21708084
[TBL] [Abstract][Full Text] [Related]
17. Ocular complications after iodine brachytherapy for large uveal melanomas.
Puusaari I; Heikkonen J; Kivelä T
Ophthalmology; 2004 Sep; 111(9):1768-77. PubMed ID: 15350335
[TBL] [Abstract][Full Text] [Related]
18. Temporal Relationship Between Visual Field, Retinal and Microvascular Pathology Following 125I-Plaque Brachytherapy for Uveal Melanoma.
Tamplin MR; Deng W; Garvin MK; Binkley EM; Hyer DE; Buatti JM; Ledolter J; Boldt HC; Kardon RH; Grumbach IM
Invest Ophthalmol Vis Sci; 2021 Jan; 62(1):3. PubMed ID: 33393969
[TBL] [Abstract][Full Text] [Related]
19. Proliferative radiation retinopathy after plaque radiotherapy for uveal melanoma.
Bianciotto C; Shields CL; Pirondini C; Mashayekhi A; Furuta M; Shields JA
Ophthalmology; 2010 May; 117(5):1005-12. PubMed ID: 20079924
[TBL] [Abstract][Full Text] [Related]
20. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
